NDA acceptance for IGXTs UNIQUE Anti-Migraine oral strip coming this Month
from SA :
" however let's look at the most promising drug in the pipeline which is the anti-migraine drug. This is a $2bn US market with current treatments which I see as basically similar. Then you have IntelGenx with a novel oral strip formulation of the very popular Maxalt (marketed by Merck and now off patent) which sold more than $600m last year. What people need to focus is that when a new formulation comes in the market; it may also expand and captures market share from pretty similar drugs if it works. Patients who have migraine issues need faster onset of action rather than better pricing and doctors are looking for drugs that are safe, fast and efficacious. People don't die from migraine but if you ever had it, you don't care how much it costs, as long as it works. I believe this anti-migraine product could be a $200-300m product at peak revenues and the timing is perfect given that I don't expect any new drugs to hit the market in the next 2-3 years. This is a 2014 event for IntelGenx and it could be important for the company history."
Josh, I know what the Company does and I understand the significance of what they do, I am having a hard time with the anonymity of the Company. In my investment experience, there are no secrets. Why does this stock fly under the radar? Please help me understand, because I think that this could be a monster?
There are so many patients like myself have tried different products. Finally, I ended up on maxalt/fioricet. If the Onset of Action is instantenous (almost) ...Trust me.....I'm counting days to get hold of this product and you have NO IDEA lot more patients like myself who would jump on this drug in an instant than you can ever imagine.